We measured plasma CRP, as a clinically-relevant marker of inflammation, which predicts future disease risk (Ridker, 2003), and used BMI as a proxy for obesity and future metabolic risk (Van Gaal et al., 2006). This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.